vs

Side-by-side financial comparison of INSPIRE VETERINARY PARTNERS, INC. (IVP) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.

cbdMD, Inc. is the larger business by last-quarter revenue ($5.0M vs $4.3M, roughly 1.2× INSPIRE VETERINARY PARTNERS, INC.). cbdMD, Inc. runs the higher net margin — -5.6% vs -58.5%, a 52.9% gap on every dollar of revenue. On growth, INSPIRE VETERINARY PARTNERS, INC. posted the faster year-over-year revenue change (6.6% vs -1.9%). cbdMD, Inc. produced more free cash flow last quarter ($-977.3K vs $-1.3M). Over the past eight quarters, cbdMD, Inc.'s revenue compounded faster (7.1% CAGR vs 2.4%).

Inspire Veterinary Partners, Inc. is a U.S.-based operator of companion animal veterinary clinics. It delivers full-spectrum pet healthcare services including preventive care, diagnostic testing, surgery, dental care, and emergency treatment for dogs, cats and other small pets, serving communities across multiple U.S. states.

cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.

IVP vs YCBD — Head-to-Head

Bigger by revenue
YCBD
YCBD
1.2× larger
YCBD
$5.0M
$4.3M
IVP
Growing faster (revenue YoY)
IVP
IVP
+8.5% gap
IVP
6.6%
-1.9%
YCBD
Higher net margin
YCBD
YCBD
52.9% more per $
YCBD
-5.6%
-58.5%
IVP
More free cash flow
YCBD
YCBD
$348.9K more FCF
YCBD
$-977.3K
$-1.3M
IVP
Faster 2-yr revenue CAGR
YCBD
YCBD
Annualised
YCBD
7.1%
2.4%
IVP

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
IVP
IVP
YCBD
YCBD
Revenue
$4.3M
$5.0M
Net Profit
$-2.5M
$-283.1K
Gross Margin
59.8%
Operating Margin
-45.6%
-5.7%
Net Margin
-58.5%
-5.6%
Revenue YoY
6.6%
-1.9%
Net Profit YoY
27.6%
-1975.7%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVP
IVP
YCBD
YCBD
Q4 25
$5.0M
Q3 25
$4.3M
$4.7M
Q2 25
$4.3M
$4.6M
Q1 25
$3.6M
$4.7M
Q4 24
$3.3M
$5.1M
Q3 24
$4.0M
$4.6M
Q2 24
$4.4M
$5.2M
Q1 24
$4.8M
$4.4M
Net Profit
IVP
IVP
YCBD
YCBD
Q4 25
$-283.1K
Q3 25
$-2.5M
$-680.0K
Q2 25
$-3.0M
$-895.3K
Q1 25
$-2.4M
$-480.8K
Q4 24
$-4.0M
$15.1K
Q3 24
$-3.5M
$-152.8K
Q2 24
$-3.4M
$459.7K
Q1 24
$-3.4M
$-3.0M
Gross Margin
IVP
IVP
YCBD
YCBD
Q4 25
59.8%
Q3 25
58.8%
Q2 25
61.5%
Q1 25
62.3%
Q4 24
66.5%
Q3 24
53.9%
Q2 24
65.8%
Q1 24
59.0%
Operating Margin
IVP
IVP
YCBD
YCBD
Q4 25
-5.7%
Q3 25
-45.6%
-14.5%
Q2 25
-61.1%
-19.6%
Q1 25
-55.2%
-10.2%
Q4 24
-46.2%
-1.7%
Q3 24
-55.2%
-6.9%
Q2 24
-54.5%
-7.4%
Q1 24
-59.2%
-35.4%
Net Margin
IVP
IVP
YCBD
YCBD
Q4 25
-5.6%
Q3 25
-58.5%
-14.4%
Q2 25
-70.8%
-19.4%
Q1 25
-66.4%
-10.1%
Q4 24
-119.4%
0.3%
Q3 24
-86.2%
-3.4%
Q2 24
-77.1%
8.9%
Q1 24
-70.8%
-68.8%
EPS (diluted)
IVP
IVP
YCBD
YCBD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-0.15
Q1 24
$-1.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVP
IVP
YCBD
YCBD
Cash + ST InvestmentsLiquidity on hand
$3.4M
Total DebtLower is stronger
$11.8M
Stockholders' EquityBook value
$4.2M
$9.0M
Total Assets
$24.0M
$11.8M
Debt / EquityLower = less leverage
2.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVP
IVP
YCBD
YCBD
Q4 25
$3.4M
Q3 25
$2.3M
Q2 25
$1.1M
Q1 25
$1.8M
Q4 24
$523.7K
$2.0M
Q3 24
$681.2K
$2.5M
Q2 24
$7.7K
$2.4M
Q1 24
$69.1K
$2.1M
Total Debt
IVP
IVP
YCBD
YCBD
Q4 25
Q3 25
$11.8M
Q2 25
$12.0M
Q1 25
$11.5M
Q4 24
$12.0M
Q3 24
$12.4M
Q2 24
$14.6M
Q1 24
Stockholders' Equity
IVP
IVP
YCBD
YCBD
Q4 25
$9.0M
Q3 25
$4.2M
$7.2M
Q2 25
$446.3K
$6.1M
Q1 25
$3.0M
$665.8K
Q4 24
$1.6M
$1.8M
Q3 24
$3.0M
$2.0M
Q2 24
$-3.1M
$3.0M
Q1 24
$269.9K
$3.1M
Total Assets
IVP
IVP
YCBD
YCBD
Q4 25
$11.8M
Q3 25
$24.0M
$10.4M
Q2 25
$20.8M
$9.9M
Q1 25
$20.7M
$10.9M
Q4 24
$20.2M
$11.5M
Q3 24
$22.4M
$10.6M
Q2 24
$21.9M
$13.8M
Q1 24
$23.4M
$14.6M
Debt / Equity
IVP
IVP
YCBD
YCBD
Q4 25
Q3 25
2.82×
Q2 25
26.96×
Q1 25
3.84×
Q4 24
7.67×
Q3 24
4.10×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVP
IVP
YCBD
YCBD
Operating Cash FlowLast quarter
$-1.3M
$-812.5K
Free Cash FlowOCF − Capex
$-1.3M
$-977.3K
FCF MarginFCF / Revenue
-30.7%
-19.5%
Capex IntensityCapex / Revenue
1.0%
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-4.3M
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVP
IVP
YCBD
YCBD
Q4 25
$-812.5K
Q3 25
$-1.3M
$-240.7K
Q2 25
$-898.3K
$-704.2K
Q1 25
$-1.4M
$-189.5K
Q4 24
$-677.5K
$-317.9K
Q3 24
$-6.3M
$167.4K
Q2 24
$149.7K
$289.8K
Q1 24
$-3.2M
$-704.1K
Free Cash Flow
IVP
IVP
YCBD
YCBD
Q4 25
$-977.3K
Q3 25
$-1.3M
$-243.6K
Q2 25
$-910.9K
$-705.7K
Q1 25
$-1.4M
$-205.0K
Q4 24
$-709.4K
$-482.3K
Q3 24
$-6.3M
$157.4K
Q2 24
$126.0K
Q1 24
$-3.3M
$-708.7K
FCF Margin
IVP
IVP
YCBD
YCBD
Q4 25
-19.5%
Q3 25
-30.7%
-5.2%
Q2 25
-21.3%
-15.3%
Q1 25
-38.3%
-4.3%
Q4 24
-21.4%
-9.4%
Q3 24
-156.4%
3.5%
Q2 24
2.9%
Q1 24
-68.8%
-16.2%
Capex Intensity
IVP
IVP
YCBD
YCBD
Q4 25
3.3%
Q3 25
1.0%
0.1%
Q2 25
0.3%
0.0%
Q1 25
0.6%
0.3%
Q4 24
1.0%
3.2%
Q3 24
0.6%
0.2%
Q2 24
0.5%
0.0%
Q1 24
3.2%
0.1%
Cash Conversion
IVP
IVP
YCBD
YCBD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-21.06×
Q3 24
Q2 24
0.63×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVP
IVP

Services$3.1M73%
Products$1.2M27%

YCBD
YCBD

Sales Channel Directly To Consumer$3.6M72%
Sales Channel Through Intermediary$1.4M28%

Related Comparisons